Herbalife Ltd. reports Q2 2026 net sales of $1.3B, a 5.4% increase, driven by strong growth in Asia Pacific and Latin America. Adjusted EBITDA at $167M.
Herbalife Ltd. reported Q2 2026 net sales of $1.3 billion, up 5.4% year-over-year and at the high end of its guidance range of 1.5% to 5.5%. This growth marks the fourth consecutive quarter of sales increases, showcasing the company's effectiveness in navigating a challenging market environment while expanding its product offerings and distributor network.
Key Takeaways
- Net sales reached $1.3 billion, a 5.4% increase compared to Q2 2025, driven by strong performance in India and Latin America.
- Adjusted EBITDA was $167 million, also at the high end of guidance, reflecting good cost management and pricing strategies.
- Gross profit margin decreased to 77.7%, down 30 basis points year-over-year, attributed to higher costs and mix changes.
- Volume growth was reported at 5.8%, marking four consecutive quarters of year-over-year improvements.
- North America saw slight growth in net sales, indicating a positive turnaround in the region after previous declines.
Consistent Growth Amidst Challenges
Herbalife's Q2 2026 net sales of $1.3 billion represent a 5.4% year-over-year increase, aligning with the company's guidance range. This growth is particularly notable against the backdrop of unfavorable foreign exchange rates and rising costs. The company experienced a 40 basis point headwind from FX rates, impacting its overall performance. However, constant currency growth reached 5.8%, indicating robust underlying demand across key markets.
| Metric | Q2 2026 | YoY | QoQ |
|---|---|---|---|
| Net Sales | $1.3B | +5.4% | N/A |
| Adjusted EBITDA | $167M | N/A | N/A |
| Gross Profit Margin | 77.7% | -30 bps | N/A |
| Volume Growth | 5.8% | N/A | N/A |
Regional Performance Highlights
The company's growth was largely fueled by strong performances in specific regions. In Asia Pacific, particularly India, net sales grew by 33% year-over-year, driven by a significant 45% increase in volume. Latin America also performed well, with reported net sales rising 17%, benefiting from favorable pricing and an 840 basis point FX tailwind. Conversely, the EMEA region faced challenges, with a reported decline of 3.5% in net sales due to volume drops.
“India has had 18 straight years of growth, and they were able to accomplish that because they've been able to build in the discipline underneath that growth,” said Stefan Graciano, CEO.
Focus on Personalized Nutrition
Herbalife continues to pivot towards personalized nutrition, integrating AI-assisted technology to enhance customer engagement. The introduction of Protocol, the company's personalized health operating system, aims to consolidate product recommendations and improve customer experiences. The positive reception of this initiative is critical, as the personalized nutrition market is projected to grow significantly, from approximately $1.9 billion in 2026 to over $10 billion by 2033, at a 27% annual growth rate.
This strategic direction aligns with the company's ongoing efforts to expand its portfolio, which now includes new products like Life IO and Activate Energy, targeting a digitally engaged customer segment prioritizing long-term health. The successful launch and continued development of these products will be crucial for sustaining growth moving forward.
Leadership Transition and Future Guidance
The upcoming retirement of CFO John DeSimone, effective at the end of the year, marks a significant transition for the company. His successor, Scott Schaefer, has been with Herbalife since 2025 and is expected to maintain the company's financial discipline while focusing on growth initiatives. The leadership transition aims to ensure continuity in the company's strategic direction and financial management.
Looking ahead, Herbalife narrowed its guidance for the third quarter, expecting net sales to increase by 0.5% to 4.5% year-over-year. Adjusted EBITDA is projected to be between $160 million and $180 million on a reported basis. Despite the headwinds from foreign exchange, the company remains optimistic about its operational efficiency and growth prospects.
Frequently Asked Questions
Did Herbalife Ltd. beat earnings estimates in Q2 2026?
Yes, Herbalife reported adjusted diluted EPS of $0.51, which exceeded consensus estimates by $0.03. The adjusted earnings were impacted by a $0.04 FX headwind compared to Q2 2025.
What were Herbalife's net sales for Q2 2026?
Herbalife's net sales for Q2 2026 were $1.3 billion, representing a 5.4% increase year-over-year and positioning the company at the high end of its guidance range.
How did foreign exchange impact Herbalife's Q2 performance?
Foreign exchange rates had a negative impact, contributing a 40 basis point headwind to net sales in Q2 2026. Despite this, the company achieved a constant currency growth of 5.8% for the quarter.
What is the outlook for Herbalife's third quarter?
For Q3, Herbalife expects net sales to grow between 0.5% and 4.5% year-over-year, factoring in a 100 basis point currency headwind. Adjusted EBITDA guidance ranges from $160 million to $180 million.
In summary, Herbalife's latest earnings reflect consistent sales growth driven by strategic product expansions and operational efficiency, while navigating foreign exchange challenges and preparing for a leadership transition. Moving forward, the focus on personalized nutrition and effective capital allocation will be key to sustaining momentum in a competitive market.
This analysis is based on public earnings call materials and is not investment advice.
